|
|
(12 intermediate revisions by the same user not shown) |
Line 65: |
Line 65: |
| | | |
| | | |
− | <p>Our aim was to transport Vitamin B<sub>12</sub>, a substance which has no known cellular exporter in nature, through the inner membrane out of the cytoplasm.<p> | + | <p>Our aim was to transport Vitamin B<sub>12</sub>, a substance which has no known cellular exporter in nature, through the inner membrane out of the cytoplasm. Our different B<sub>12</sub> Synporter proteins consist of a TorA signal peptide that mediates export through the Twin Arginine Translocation (Tat) system, linked to a B<sub>12</sub>-binding protein domain. This construct was produced, together with B<sub>12</sub>, by the B<sub>12</sub> prototrophic enterobacteria <em>R. planticola</em> and <em>S. blattae</em>.<p> |
− | | + | |
− | | + | |
− | <p>Our different B<sub>12</sub> Synporter proteins consist of TorA signal peptide for a Twin Arginine Transporter (Tat) mediated export that is linked to a B<sub>12</sub>-binding domain. This construct was produced, together with B<sub>12</sub>, by the B<sub>12</sub> autotrophic <em>R. planticola</em> and <em>S. blattae</em>. First, we could show that the Synporter proteins were translocated into the periplasm. Moreover, most important, we could also prove the enrichment of B<sub>12</sub> in the periplasm, which proofs that our Synporter is functional.</p>
| + | |
| | | |
| <hr> | | <hr> |
Line 74: |
Line 71: |
| <hr> | | <hr> |
| | | |
− | <p>Thereby, Vitamin B<sub>12</sub> can also be regarded as a prime example which is what we want to state with our work. In principle, a Synporter should work with basically any chemical (that can form a non-covalent bond to a protein), which is desired to be exported out of a cell. This is the first time reported that a high-molecular compound as B<sub>12</sub> was translocated through a cellular membrane, which makes our Synporter so innovative.</p>
| |
| | | |
− | <p>This concept can be applied for the production of all natural chemicals which are synthesized, but not exported due to the lack of a cellular exporter. Furthermore, it can also be applied for the production of artificial molecules which can be produced by synthetic metabolic engineering in a cell. Using our Synporter approach, no cell lysis is required any more for the industrial production, which makes the production process significantly easier and cheaper.</p> | + | <p>We were able to detect the Synporter proteins in the periplasm of the two organisms (see <a href="https://2016.igem.org/Team:Goettingen/Results#western">expression test</a>, proving that the Tat mediated translocation was successful. Moreover, most important, we could also prove a significantly increased overall B<sub>12</sub> production in the cells expressing the Synporter protein, compared to the cells containing an empty plasmid (see <a href="https://2016.igem.org/Team:Goettingen/Proof#final">B<sub>12</sub> assay</a>). This increased production is mainly due to the fact that the cells have to compensate for the B<sub>12</sub> leaving the cytoplasm bound to the Synporter. Thus, it proves the functionality of our system.</p> |
| + | <p>This is the first time reported that a compound of such a high-molecular weight as B<sub>12</sub> was translocated through a cellular membrane without a native exporter. Therefore, our Synporter is truly innovative!</p> |
| + | |
| + | |
| + | <p>Vitamin B<sub>12</sub> can also be regarded as a prime example for how highly valuable compounds can be gained from production organisms. In principle, a Synporter should work with basically any desired chemical compound, if a protein counterpart exists which can be used as Synporter binding domain. This concept could be applied for the production of all natural chemicals which are synthesized by microorganisms, but not exported due to the lack of a native cellular exporter. Furthermore, this principle could also be applied for the production of artificial molecules which can be produced by synthetic metabolic engineering in a cell. Using our Synporter approach, no cell lysis would be required any more for the industrial production. This concept has the potential to make the production process significantly easier and cheaper.</p> |
| + | |
| + | <hr> |
| + | |
| + | <img id="final" src="https://static.igem.org/mediawiki/2016/4/45/T--Goettingen--Result_Graph.png" class="photo" style="width:80%;" /> |
| + | <div class="caption"> |
| + | <p><b>Fig. 5: Final results of the photometric assay.</b> The plot shows the quantity of B<sub>12</sub> per amount of protein, in the periplasmic fraction and the cytoplasmic fraction.</p> |
| + | </div> |
| + | <hr> |
| + | |
| | | |
| | | |